期刊文献+

选择性COX-2抑制剂NS398对前列腺癌PC-3细胞增殖与凋亡的影响 被引量:4

Effect of selective cyclooxygenase-2 inhibitor NS398 on the proliferation and apoptosis of prostate cancer cell line PC-3 in vitro
下载PDF
导出
摘要 目的观察环氧化酶-2(COX-2)抑制剂NS398对前列腺癌细胞PC-3增殖和凋亡的影响。方法采用四甲基偶氮唑蓝法(MTT法)检测不同浓度和不同时间NS398对PC-3细胞增殖的影响;RT-PCR法检测不同浓度NS398作用PC-3细胞24h后COX-2 mRNA的表达;酶联免疫测定法(ELISA)检测不同浓度NS398作用PC-3细胞24h后PGE2释放水平;流式细胞仪检测不同浓度NS398作用PC-3细胞24h后细胞凋亡情况。结果NS398可以抑制PC-3细胞的增殖,呈时间和剂量依赖性;RT-PCR和ELISA法检测结果显示,随着NS398浓度增高,PC-3细胞COX-2 mRNA表达和PGE2释放水平呈下调趋势;细胞凋亡检测结果显示100、200μmol/LNS398对PC-3细胞具有诱导凋亡的作用。结论NS398可能通过COX-2依赖性途径抑制前列腺癌PC-3细胞增殖,促进肿瘤细胞凋亡。 Objective To investigate the effect of cyclooxygenase-2 inhibitor NS398 on the proliferation and apoptosis of prostate cancer cell line PC-3 in vitro. Methods The proliferative inhibition of PC-3 cells was observed by methyl thiazol tetrazolium(MTT) rapid photocolorimetric assay; the expression of COX-2 mRNA in cultured PC-3 cells was examined by RT- PCR; the release levels of PGEz was measured by enzyme-linked immunosorbent assay(ELISA) ; PC-3 cells cultured in different concentrations of NS398 medium for 24 h was marked with Annexin V-FITC and PI for the cell apoptosis assay by flow cytometry. Results After the PC-3 cells were treated with different concentrations of NS398, the inhibitory rate on proliferation increased with the increasing of concentration and days. The expression of COX-2 mRNA and the release levels of PGF2 were decreased compared with those of the control group. PC-3 cells cultured in 100 and 200 μmol/L NS398 medium for 24 h had significantly higher incidence of apoptosis. Conclusion NS398 can inhibit proliferation of human prostate cancer cell line PC-3 and induce its apoptosis in vitro, which may contributed to the COX-2 dependent pathway.
出处 《现代泌尿外科杂志》 CAS 2007年第5期292-294,共3页 Journal of Modern Urology
基金 苏州大学附属第一医院面上项目课题(No.H05014)
关键词 前列腺癌 环氧化酶抑制剂 增殖 凋亡 prostate cancer cyclooxygenase inhibitor, proliferation apoptosis
  • 相关文献

参考文献8

  • 1Gupta S,Srivastava M,Ahmad N,et al.Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma[J].Prostate,2000,42(1):73-78.
  • 2Lee LM,Pan CC,Cheng CJ,et al.Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia[J].Anticancer Res,2001,21(2B):1291.1294.
  • 3丁翔,严春寅,温端改,侯建全,浦金贤.COX-2、bcl-2和PCNA在前列腺癌中的表达及其意义[J].苏州大学学报(医学版),2005,25(1):110-112. 被引量:10
  • 4Courtney ED,Melville DM,Leicester RJ.Review article:chemoprevention of colorectal cancer[J].Aliment Pharmacol Ther,2004,19(1):1-24.
  • 5Tajamul H,Sanjay G,Hasan M.Cyclooxygenase-2 and prostate carcinogenesis[J].Cancer Letters,2003,191(2):125-135.
  • 6Kirschenbaum A,Liu X,Yao S,et al.The role of cyclooxygenase-2 in prostate cancer[J].Urology,2001,58(2A):127-131.
  • 7Han C,Lens J,Demetris AJ,et al.Cyclooxygenase-2 promotes human cholangiocarcinoma growth:evidence for cyclooxygenase2-independent mechanism in celecoxib-mediated induction of p21^waf1/cip1 and p27^kip1 and cell cycle arrest[J].Cancer Res,2004,64(4):1369-1376.
  • 8Pruthi RS,Derksen ED,Moore D.A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy[J].Br J Urol,2004,93(3):275-278.

二级参考文献9

  • 1Kirschenbaum A, Klausner AP, Lee R, et al. Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in the human prostate[ J ]. Urology, 2000, 56: 671 - 676.
  • 2Zha S, Gage WR, Jsauvageot J, et al. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma [ J ] . Cancer Res,2001,61: 8617 - 8623.
  • 3Subbarayan V, Sabichi AL, Llansa N, et al. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells[J]. Cancer Res, 2001,61:2720 - 2726.
  • 4Madaan S, Abel PD, Chaudhary KS, et al. Cytoplasmic induction and overexpression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment[J]. BJU Int, 2000, 86:736 - 741.
  • 5Lee LM, Pan C C, Cheng C J, et al. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia [J ]. Anticancer Res, 2001, 21 :1291 - 1294.
  • 6Tanji T, Kikigawa T, Yokoyama M, et al. Immunohistochemistry study of cyclooxygenases in prostatic adenocarcinoma: relationship to apoptosis and bcl-2 protein expression[J]. Anticancer Res, 2000, 20: 2313 - 2320.
  • 7Hussain T, Gupta S, Mukhtar H, Cy-clooxygenase-2 and prostate carcinogenesis [ J ]. Cancer Letters, 2003, 191:125 - 135.
  • 8Chaudhary K S, Abel P D, Lalani E N, Role of the Bcl-2gene family in prostate cancer progression and its implications for therapeutic intervention[J]. Environ Health Perspect, 1999, 107: 49 - 57.
  • 9Derksen JE, Pruthi RS. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors[ J ]. Urology, 2003, 169: 2352 - 2359.

共引文献9

同被引文献48

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部